In experiments in rats and mice, two researchers from Johns Hopkins University have reported the successful use of nanoparticles to deliver gene therapy for wet age-related macular degeneration – an eye disease characterized by abnormal blood vessel growth that damages the light-sensitive tissue in the back of the eye. The research provides evidence of the potential value of nanoparticle-delivered gene therapy to treat wet age-related macular degeneration as well as rare, inherited blinding diseases of the retina.
An official website of the United States government.